This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Voronoi Inc., Dana-Farber-Cancer Institute Inc.. Active years: 2025.
Company Filing History:
2 out of 11 
1 out of 1,264 
Years Active: 2025
Title: Jungbeom Son: Innovator in Pharmaceutical Chemistry
Introduction
Jungbeom Son is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target neurodegenerative diseases and various cancers. With a total of 2 patents, his work is paving the way for innovative treatments.
Latest Patents
One of Jungbeom Son's latest patents is titled "Pyrrolopyrimidine inhibitors of wild-type and mutant forms of LRRK2." This invention discloses compounds that possess inhibitory activity against LRRK2, along with pharmaceutical compositions containing these compounds. These innovations are aimed at treating neurodegenerative diseases and disorders such as Parkinson's disease and brain cancer, including gliomas and glioblastomas.
Another significant patent is "Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related disease." This invention relates to a pyrrolopyridine derivative that serves as an active ingredient in pharmaceutical compositions for the prevention or treatment of protein kinase-related diseases. The derivative exhibits excellent inhibitory activity against various protein kinases, including LRRK2, DYRK1, and CLK1, and shows a strong suppressive effect on the growth of triple-negative breast cancer cells.
Career Highlights
Jungbeom Son has worked with prominent organizations such as Voronoi Inc. and Dana-Farber Cancer Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Namdoo Kim and Jieun Choi. Their collaborative efforts have further enhanced the impact of his research and innovations.
Conclusion
Jungbeom Son is a distinguished inventor whose work in pharmaceutical chemistry is making strides in the treatment of serious diseases. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.